These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. QSAR--how good is it in practice? Comparison of descriptor sets on an unbiased cross section of corporate data sets. Gedeck P; Rohde B; Bartels C J Chem Inf Model; 2006; 46(5):1924-36. PubMed ID: 16995723 [TBL] [Abstract][Full Text] [Related]
7. Development of quantitative structure-activity relationships and classification models for anticonvulsant activity of hydantoin analogues. Sutherland JJ; Weaver DF J Chem Inf Comput Sci; 2003; 43(3):1028-36. PubMed ID: 12767162 [TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship modeling of the toxicity of organothiophosphate pesticides to Daphnia magna and Cyprinus carpio. Zvinavashe E; Du T; Griff T; van den Berg HH; Soffers AE; Vervoort J; Murk AJ; Rietjens IM Chemosphere; 2009 Jun; 75(11):1531-8. PubMed ID: 19376559 [TBL] [Abstract][Full Text] [Related]
9. Relationships between Molecular Complexity, Biological Activity, and Structural Diversity. Schuffenhauer A; Brown N; Selzer P; Ertl P; Jacoby E J Chem Inf Model; 2006; 46(2):525-35. PubMed ID: 16562980 [TBL] [Abstract][Full Text] [Related]
10. Antioxidant QSAR modeling as exemplified on polyphenols. Lucić B; Amić D; Trinajstić N Methods Mol Biol; 2008; 477():207-18. PubMed ID: 19082949 [TBL] [Abstract][Full Text] [Related]
11. CAUTION: popular "benchmark" data sets do not distinguish the merits of 3D QSAR methods. Manchester J; Czermiński R J Chem Inf Model; 2009 Jun; 49(6):1449-54. PubMed ID: 19438212 [TBL] [Abstract][Full Text] [Related]
12. A general method for exploiting QSAR models in lead optimization. Lewis RA J Med Chem; 2005 Mar; 48(5):1638-48. PubMed ID: 15743205 [TBL] [Abstract][Full Text] [Related]
13. QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design. Massarelli I; Macchia M; Minutolo F; Prota G; Bianucci AM Bioorg Med Chem; 2009 May; 17(10):3543-56. PubMed ID: 19398207 [TBL] [Abstract][Full Text] [Related]
14. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications. Itskowitz P; Tropsha A J Chem Inf Model; 2005; 45(3):777-85. PubMed ID: 15921467 [TBL] [Abstract][Full Text] [Related]
15. Modelling inhalational anaesthetics using bayesian feature selection and QSAR modelling methods. Manallack DT; Burden FR; Winkler DA ChemMedChem; 2010 Aug; 5(8):1318-23. PubMed ID: 20540061 [TBL] [Abstract][Full Text] [Related]
16. Prediction and mechanistic interpretation of human oral drug absorption using MI-QSAR analysis. Iyer M; Tseng YJ; Senese CL; Liu J; Hopfinger AJ Mol Pharm; 2007; 4(2):218-31. PubMed ID: 17397237 [TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-retention relationship for the Kovats retention indices of a large set of terpenes: a combined data splitting-feature selection strategy. Hemmateenejad B; Javadnia K; Elyasi M Anal Chim Acta; 2007 May; 592(1):72-81. PubMed ID: 17499073 [TBL] [Abstract][Full Text] [Related]
18. Quantum mechanical quantitative structure-activity relationships to avoid mutagenicity. Holder AJ; Ye L Dent Mater; 2009 Jan; 25(1):20-5. PubMed ID: 18584863 [TBL] [Abstract][Full Text] [Related]
19. Combinatorial QSAR modeling of P-glycoprotein substrates. de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744 [TBL] [Abstract][Full Text] [Related]
20. Exploiting structure-activity relationships in docking. Sullivan DC; Martin EJ J Chem Inf Model; 2008 Apr; 48(4):817-30. PubMed ID: 18399649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]